Intensity Therapeutics Inc (INTS)’s stock is trading at $0.32 at the moment marking a fall of -1.47% from the last session close. As of this writing, shares are priced at -93.82% less than their 52-week high of $5.10, and 21.18% over their 52-week low of $0.26. Based on the past 30-day period, the stock price is -54.19% below the high and +19.72% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, INTS’s SMA-200 is $2.1296.
INTS’s price to book ratio for the most recent quarter was 14.41, resulting in an 8.84 price to cash per share for the period.
How does Intensity Therapeutics Inc (INTS) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 3 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.00 in simple terms.
Intensity Therapeutics Inc (INTS): Earnings History
If we examine Intensity Therapeutics Inc’s recent earnings history, in the last quarter ended on 3/31/2025, it posted adjusted earnings per share of -$0.22, beating the consensus of -$0.13. In other words, it beat the consensus by -$0.09, resulting in a -69.23% surprise. In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.22 in contrast with the Outlook of -$0.13. That was a difference of -$0.09 and a surprise of -69.23%.
Intensity Therapeutics Inc (NASDAQ: INTS) Ownership Details
I will give a breakdown of the key shareholders in Intensity Therapeutics Inc (INTS). Recent figures show that the company’s insiders hold 23.59% of shares. A total of 23 institutional investors hold shares in the company, making 9.99% of its stock and 13.08% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Sapient Capital LLC holding total of 976.8 shares that make 3.75% of the company’s total number of shares and are currently priced at 0.31 million.
The securities firm Armistice Capital, LLC holds 872.55 shares of INTS, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.35% , and the holding percentage of shares is valued at 0.28 million.
An overview of Intensity Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Intensity Therapeutics Inc (INTS) traded 2,552,734 shares per day, with a moving average of $0.3853 and price change of -0.1637. With the moving average of $0.5549 and a price change of -1.5485, about 1,548,888 shares changed hands on average over the past 50 days. Finally, INTS’s 100-day average volume is 787,962 shares, alongside a moving average of $1.3395 and a price change of -1.9485.
